Published March 10. 2021 4:40PM By Lee Elci Kudos and credit for everything I'm about to share should be directed towards Tony De Angelo, managing director of the Connecticut-based Paragon Trust Company. Tony is a weekly contributor to my radio show, and since the onset of COVID-19 has doggedly pursued questions about the myriad and nebulous financial dealings of Connecticut Gov. Ned Lamont, his wife Ann, her Hedge Fund Oak HC/FT, and those in his orbit. Without Tony's unyielding investigation much of this information would have gone unseen. Oak HC/FT is a premier venture growth equity fund investing in health care information and financial services technology, according to its website. We know from viewing the Oak HC/FT website that Sema4 is a startup biotech corporation owned and propounded by Oak HC/FT. Sema4 received a no-bid contract from Connecticut for COVID-19 testing at an undisclosed price, as outlined in a June 2020 Hartford Courant article. And even as pressures mounted concerning this ostensible matter of self-dealing, the governor’s Chief Operating Officer Josh Geballe, caustically reminded us that we were fortunate to have Sema4 as a partner against the virus.